Ultragenyx

3 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Ultragenyx Pharmaceutical is slashing its workforce by 20% and reducing its real estate footprint to halve research and development spending.

4 sources 4 articles v 2 16h ago

◼ Archived Business

FDA approves Ultragenyx's gene therapy Fayuvi for Sanfilippo syndrome at a price of $3.95 million.

5 sources 6 articles v 3 48d ago

◼ Archived Business 🔮 fades ✗

5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

11 sources 13 articles v 11 62d ago